Navigation Links
Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results
Date:11/5/2009

expense) income, net (145,979) (88,336) (742,411) (71,653) -------- ------- -------- ------- Net loss $(11,441,105) $(13,748,995) $(30,178,549) $(43,062,746) ============ ============ ============ ============ Basic and diluted net loss per share(1) $(0.23) $(0.36) $(0.63) $(1.18) ====== ====== ====== ====== Shares used to compute basic and diluted net loss per share(1) 50,364,493 38,116,063 48,189,177 36,371,272 ========== ========== ========== ========== (1) As a result of the issuance of 12,039,794 shares of common stock pursuant to a private placement in the first quarter of 2009 and 9,240,307 shares of common stock pursuant to an effective shelf registration in the first quarter of 2008, there is a lack of comparability in the per share amounts between the 2009 and 2008 periods presented.
                           CADENCE PHARMACEUTICALS, INC.
                           (a development stage company)
                             CONDENSED BALANCE SHEETS

                                                   September 30,  December 31,
                                                       2009           2008
                                                       ----           ----
                                                    (unaudited)
                     Assets
    Current assets:
      Cash, cash equivalents and short-term
       investments                                   $96,552,282  $47,627,246
      Restricted cash                                  1,695,696    2,195,696
      Prepaid expenses and other current assets          569,427      219,674
                                                         -------    
'/>"/>
SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the JMP Securities Healthcare Focus Conference in New York on October 6, 2009
2. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Canaccord Adams Global Growth Conference in Boston on August 11, 2009
3. Cadence Pharmaceuticals Announces Priority Review and Acceptance of NDA Submission for Acetavance(TM) for Treatment of Acute Pain and Fever
4. Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer
5. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Needham Life Sciences Conference in New York on June 11, 2009
6. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2009 Financial Results on May 7, 2009
7. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Cowen & Companys 29th Annual Health Care Conference in Boston on March 16, 2009
8. Cadence Pharmaceuticals Completes $86.6 Million Private Placement of Common Stock
9. Cadence Pharmaceuticals to Raise $86.6 Million in a Private Placement of Common Stock
10. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the BIO CEO and Investor Conference in New York City
11. Cadence Pharmaceuticals Announces Positive Topline Results of Phase III Clinical Trial of Acetavance in Laparoscopic Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... Red Deer, Alberta (PRWEB) , ... July 03, 2015 , ... ... Camp host their 24-Hour Train-a-Thon where they provide members of the Red Deer community ... This year’s full day of fitness training, games, food, events and entertainment raised thousands ...
(Date:7/2/2015)... ... ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its newest location ... The premium frozen yogurt chain was listed as #22 on the Inc. 500 list ... New Albany, MS 38652, will have a grand opening event on July 4, 2015 ...
(Date:7/2/2015)... ... ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its newest ... the Lone Star State. The premium frozen yogurt chain was listed as #22 on ... opened July 1 at Duke’s Travel Plaza, is located at:, 30176 Hwy 64, Suite ...
(Date:7/2/2015)... ... 02, 2015 , ... The American Association of Poison Control ... Overdose Stat (S.O.S.) Act of 2015 on June 23, 2015. Together with the ... decrease drug overdose – especially of heroin and opioid medication – by expanding ...
(Date:7/2/2015)... ... July 02, 2015 , ... Many Fourth of July celebrations ... why Amica Insurance is sharing some tips to promote the proper use ... people go to the emergency room daily with fireworks-related injuries in the month surrounding ...
Breaking Medicine News(10 mins):Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3Health News:sweetfrog Opens First Location in Mississippi 2Health News:sweetFrog Expands Texas Footprint with Location in Canton 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 3Health News:6 Fireworks Safety Tips from Amica Insurance 2
... marital status can factor into the overall survival of ... most significant factor impacting overall survival, according to a ... Thoracic Oncology, sponsored by ASTRO, ASCO, IASLC and the ... in 2008 approximately 215,020 new cases of lung cancer ...
... small tissue samples from patients with lung cancer and ... is now being utilized to better tailor the chemotherapy ... cell lung cancer, according to a study presented at ... by ASTRO, ASCO, IASLC and the University of Chicago., ...
... targeted therapies called monoclonal antibodies showed no safety ... non-small cell lung cancer according to a study ... Thoracic Oncology, sponsored by ASTRO, ASCO, IASLC and ... and chemotherapy has been shown to increase the ...
... UPTON, NY A new study at the ... suggests that vigabatrin (a.k.a. gamma vinyl-GABA, or GVG) ... associate methamphetamine with a particular environment. Specifically, animals ... in a location where they had previously been ...
... one milliard of a metre in size are widely ... There are also significant amounts of nanoparticles in exhaust ... health effects, because only a very small portion of ... safety risks. Nanoparticles have even been dubbed the asbestos ...
... Plans, Including Medicare Advantage & Managed Medicaid, Bring,The ... BRAUNFELS, Texas, Nov. 13 In a move,expanding ... today,announced agreements with 17 insurance companies that will ... obtain power mobility equipment,from The SCOOTER Store when ...
Cached Medicine News:Health News:Chemotherapy plus targeted therapies shows improved survival in advance-stage lung cancer patients 2Health News:Hope for treating relapse to methamphetamine abuse 2Health News:Hope for treating relapse to methamphetamine abuse 3Health News:Nanoparticles trigger cell death? 2Health News:The SCOOTER Store Expands Power Mobility Products, Services to 7 Million Health Plan Members 2
(Date:7/2/2015)... 2, 2015 Pharma Major Lupin Limited ... "Biocom" in Russia subject to certain ... pharmaceutical market which recorded RUB 765 billion in sales, placing ... the world in 2014 (IMS Health). For over a decade, ... continue with this trend, projecting Russia ...
(Date:7/2/2015)... CAMBRIDGE, Mass. , and DURHAM, N.C. ... Sciences , Inc. today announced its acquisition of assets ... Inc. (NYSE: PFE ) that had previously been ... Inc.  XRPro Sciences also acquired all of Pfizer,s rights ... re-launching the Icagen brand and will provide comprehensive services ...
(Date:7/2/2015)... 2015 Research ... addition of the "2015 New Frontiers ... Emerging Technologies, Competitive Landscape" report to ... in Clinical Chemistry and Immunodiagnostics: Global Challenges, ... seven-country strategic analysis of major business opportunities ...
Breaking Medicine Technology:Lupin Acquires Biocom in Russia 2Lupin Acquires Biocom in Russia 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 4New Frontiers in 2015 Global Clinical Chemistry and Immunodiagnostics Market: Challenges, Emerging Technologies, Competitive Landscape 2
... (OTC: HEWA) a leading VIPPS accredited retail mail-order pharmacy, ... ended September 30, 2011. In the ... increased $1,567,764 to $2,783,240, up 129% compared to the ... strength in its prescription business.  Prescriptions filled increased from ...
... Nov. 17, 2011 Cohera Medical, a rapidly growing ... selling its lead product, TissuGlu® Surgical Adhesive, to hospitals ... regional launch will document and highlight the advantages of ... expansion throughout Germany and to additional European markets in ...
Cached Medicine Technology:HealthWarehouse.com Reports 129% Quarter-Over-Quarter Revenue Growth in the Third Quarter 2011 2Cohera Medical Commercializes TissuGlu® Surgical Adhesive in Germany 2Cohera Medical Commercializes TissuGlu® Surgical Adhesive in Germany 3
... The eNclose Anastomosis ... specifically to obviate the ... of the aorta. The ... the surgeon with a ...
12mm Blades, Maximum Spread 18mm, Spring Action, Wire - Pediatric; in stainless steel...
15mm Open Blades, Thumb Screw Control; in Titanium....
15mm Open Blades, 28mm Maximum Spread; Available in small(S) and large (L), in stainless steel....
Medicine Products: